Survival benefit of lymph node dissection and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma
摘要
Lymph node metastasis (LNM) is strongly associated with a poor survival in patients with intrahepatic cholangiocarcinoma (ICC). However, the indications for lymph node dissection (LND) are controversial. This study assessed the accuracy of preoperative imaging for detecting LNM.
MethodsEighty-nine patients who underwent curative resection for ICC between 2001 and 2022 were enrolled and analyzed retrospectively. Lymph node status was evaluated preoperatively using contrast-enhanced computed tomography (CT) and positron emission tomography (PET)/CT. Patients were grouped according to their LND status (LND or no LND). Patients in the LND group were further grouped according to pathological LNM status (pN+, LNM-positive; and pN0, LNM-negative).
ResultsAdequate LND was performed in 44 (49.4%) patients, among whom LNM was diagnosed in 17 (38.6%). The 3-year overall survival rates in patients with LND/pN+, LND/pN0, and no LND were 16.2%, 70.0%, and 70.7%, respectively. The corresponding 3-year recurrence-free survival rates were 11.8, 52.6, and 42.6%, respectively. A lymph node diameter > 8 mm on preoperative CT was an independent predictor of LNM. The maximum standardized uptake value (SUVmax) on PET/CT was significantly associated with LNM.
ConclusionLymph node diameter and SUVmax predicted LNM in patients with resectable ICC. A preoperative lymph node evaluation can ensure optimal treatment outcomes.